The Pink Study
The Pink study is an ongoing clinical performance trial dedicated to the early detection of Breast cancer.
Our researchers are actively working to develop innovative methods to detect Breast cancer at its earliest stages, where treatment options are most effective, while helping prevent unnecessary intervention and stress.
Enrollment is open, access the form below.
Active Study
SpotitEarly has completed its first large-scale clinical study and is now preparing to launch two additional trials in the United States. These upcoming trials represent the next phase in expanding the clinical evidence base for our technology and reflect our commitment to advancing early cancer detection worldwide.
Partnership Acknowledgement
The Pink Study
SpotitEarly is proud to partner with The Hennessy Institute at Hackensack Meridian Health on a new research study in New Jersey for early breast cancer detection. For more information on how to participate, please contact the Hennessy Institute research team at HICAPResearch@hmhn.org .
The Hennessy Institute at Hackensack Meridian Health
Who Can Join
Enrolling
The Pink Study is currently open to participants residing in New Jersey only through our partnership with The Hennessy Institute at Hackensack Meridian Health. We are seeking women who are either due for their annual breast cancer screening (mammogram, ultrasound, or MRI) or are scheduled for a breast biopsy.
All clinical studies are conducted under the oversight of an Institutional Review Board (IRB) to ensure participant safety and adherence to the highest ethical research standards.
If you meet these criteria and would like more information on how to participate, please contact the Hennessy Institute research team at HICAPResearch@hmhn.org.
Click the button below to access the enrollment form.